AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States... Show more
AMN Healthcare Services is one of the largest healthcare workforce and staffing providers in the United States, connecting hospitals and clinics with travel nurses, allied professionals, physicians, and technology solutions. Its quarterly results serve as a barometer for healthcare labor demand, which has been volatile since the pandemic-driven staffing surge cooled. After several quarters of normalization, investors have watched closely for signs of a durable rebound in travel nurse and allied volumes. A sharp third-quarter beat driven partly by labor disruption reserve adjustments—rather than purely organic demand—raises important questions about the sustainability of margins, making this report a key reference point for gauging the company's earnings trajectory heading into 2027.
For the third quarter of 2026, AMN Healthcare Services reported revenue of $717.3 million, a 13% increase from the prior-year period and roughly $68 million above the consensus estimate of about $648.9 million. Adjusted EPS was $1.16, compared with analyst expectations of $0.23, while GAAP net income was $0.83 per share. Net income totaled $33 million, up from $29 million a year earlier.
The revenue upside was driven by strong performance in travel nurse and allied staffing, along with $59 million of labor disruption revenue versus the $7 million the company had assumed in its guidance. The additional revenue consisted largely of reserve adjustments tied to prior labor disruption events. These adjustments lifted reported gross margin to 31.9%, or 440 basis points above the top end of guidance, and added roughly 520 basis points to gross margin. Adjusted EBITDA reached $94 million, or 13% of revenue.
Segment results were mixed. Nurse and Allied revenue was $460 million, with travel nurse volume up 21% year over year and allied volume up 12%. Physician and Leadership Solutions revenue fell 4% to $171 million, while Technology and Workforce Solutions revenue declined 9% to $86 million, reflecting continued pricing pressure in language services.
For the fourth quarter, the company guided revenue to a range of $655 million to $670 million, above the consensus of approximately $653.8 million, with adjusted EBITDA margin expected between 5.8% and 6.3%.
Tickeron's AI Screener is an AI-powered stock and ETF (exchange-traded fund) discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps surface trade ideas, trending stocks, breakout candidates, and market opportunities far more efficiently than manual screening. Explore the AI Screener to see how data-driven filtering can sharpen your own research workflow.
Shares of AMN Healthcare Services rose about 3% in after-hours trading following the release, reflecting investor relief that results landed well ahead of expectations. The magnitude of the beat, however, was amplified by non-recurring reserve adjustments related to prior labor disruption events, which some analysts and investors may discount when assessing underlying profitability. Sentiment entering the quarter had been cautious given ongoing pricing pressure in language services and the vendor management system (VMS) business. The after-market gain suggests the market focused on the top- and bottom-line upside, though the sustainability of margins excluding these adjustments remains a central question for the stock's longer-term direction.
Investors will now shift attention to whether AMN Healthcare Services can convert its third-quarter momentum into consistent organic growth. Management's fourth-quarter revenue guidance of $655 million to $670 million implies a sequential step down from the $717.3 million reported in the third quarter, as the elevated labor disruption revenue is not expected to repeat. This makes the underlying demand trends in travel nurse and allied staffing the most important variable to track.
Another key factor is international nurse volume. The company reported 32% year-over-year growth in the segment during the third quarter but expects volumes to decline sequentially beginning in the fourth quarter until embassy visa appointments normalize. This adds a degree of uncertainty to near-term results.
Margin durability will also be in focus. Excluding the labor disruption reserve adjustments, gross margin would have been considerably lower, so investors should monitor whether travel nurse bill rates and allied pricing can stabilize. Finally, the Technology and Workforce Solutions segment continues to face pricing pressure in language services, and management has signaled potential gross margin benefits from its global workforce strategy in the first half of next year. How these initiatives progress will help determine the path of profitability into 2027.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of healthcare staffing and workforce services
Industry HospitalNursingManagement